Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

First-line chemotherapy for metastatic breast cancer (MBC) with docetaxel (T), carboplatin (C), and traztuzumab (H) (TCH): A phase II trial

First-line chemotherapy for metastatic breast cancer (MBC) with docetaxel (T), carboplatin (C), and traztuzumab (H) (TCH): A phase II trial. Journal of Clinical Oncology, ASCO Annual Meeting Proceedings. 2003.


© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.